SARAH SCHWARTZ: Open Payments
NPI 1437658705 · NORTHGLENN, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,289 in 57 payments from 13 companies in 2025. Trend: 2023 $730 · 2024 $1,207 · 2025 $1,289
Food & beverage: $1,289
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $487 |
| Ardelyx, Inc. | 5 | $163 |
| Gilead Sciences, Inc. | 4 | $121 |
| Phathom Pharmaceuticals, Inc. | 3 | $105 |
| Janssen Biotech, Inc. | 4 | $98 |
| Madrigal Pharmaceuticals | 3 | $84 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $55 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $55 |
| Aimmune Therapeutics, Inc. | 2 | $37 |
| GENZYME CORPORATION | 1 | $24 |
Products named: RINVOQ, IBSRELA, SKYRIZI, VOQUEZNA, TREMFYA, REZDIFFRA, LINZESS, CREON.
Industry payments across CO — which companies pay providers there.
